Protein interactions: Mapping interactome networks to support drug target discovery and selection

Methods in Molecular Biology

Volumn 910, Issue , 2012, Pages 279-296

  De Las Rivas, Javier ^a   Prieto, Carlos ^b  

^a CSIC   (Spain)

^b Institute of Biotechnology INBIOTEC Parque Científico de León   (Spain)

Author keywords

Drug target; Interactome; PPI; Protein interaction; Protein network

Indexed keywords

DRUG DEVELOPMENT; METHODOLOGY; MOLECULARLY TARGETED THERAPY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVIEW;

DRUG DISCOVERY; MOLECULAR TARGETED THERAPY; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS;

EID: 84864844191     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-965-5_12     Document Type: Review

References (80)

1. Cusick ME et al (2005) Interactome: gateway into systems biology. Hum Mol Genet 14(2):R171-R181 (Pubitemid 41631885)
2. Merico D, Gfeller D, Bader GD (2009) How to visually interpret biological data using networks. Nat Biotechnol 27(10):921-924
3. Boone C, Bussey H, Andrews BJ (2007) Exploring genetic interactions and networks with yeast. Nat Rev Genet 8(6):437-449 (Pubitemid 46789246)
4. De Las Rivas J, de Luis A (2004) Interactome data and databases: different types of protein interaction. Comp Funct Genomics 5(2):173-178 (Pubitemid 38744654)
5. De Las Rivas J, Fontanillo C (2010) Protein-protein interactions essentials: key concepts to building and analyzing interactome networks. PLoS Comput Biol 6(6):e1000807
6. Prieto C et al (2008) Human gene coexpression landscape: con fi dent network derivedfrom tissue transcriptomic pro fi les. PLoS One 3(12):e3911
7. Przytycka TM, Singh M, Slonim DK (2010) Toward the dynamic interactome: it's about time. Brief Bioinform 11(1):15-29
8. Boehr DD, Wright PE (2008) Biochemistry. How do proteins interact? Science 320(5882): 1429-1430
9. Mackay JP et al (2007) Protein interactions: is seeing believing? Trends Biochem Sci 32(12): 530-531.
10. Prieto C, De Las Rivas J (2006) APID: Agile Protein Interaction Data analyzer. Nucleic Acids Res 34(Web Server Issue): W298-W302. (Pubitemid 44529782)
11. Dreze M et al (2010) High-quality binary interactome mapping. Methods Enzymol 470:281-315.
12. Suter B, Kittanakom S, Stagljar I (2008) Twohybrid technologies in proteomics research. Curr Opin Biotechnol 19(4):316-323.
13. Uetz P et al (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae . Nature 403(6770):623-627. (Pubitemid 30103994)
14. Ito T et al (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA 98(8): 4569-4574. (Pubitemid 32295017)
15. Giot L et al (2003) A protein interaction map of Drosophila melanogaster . Science 302(5651): 1727-1736. (Pubitemid 37505730)
16. Formstecher E et al (2005) Protein interaction mapping: a Drosophila case study. Genome Res 15(3):376-384. (Pubitemid 40467779)
17. Stelzl U et al (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122(6):957-968. (Pubitemid 41345212)
18. Rual JF et al (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437(7062):1173-1178.
19. Cusick ME et al (2009) Literature-curated protein interaction datasets. Nat Methods 6(1):39-46.
20. Salwinski L et al (2009) Recurated protein interaction datasets. Nat Methods 6(12): 860-861.
21. Stark C et al (2006) BioGRID: a general repository for interaction datasets. Nucleic Acids Res 34(Database Issue):D535-D539.
22. Salwinski L et al (2004) The database of interacting proteins: 2004 update. Nucleic Acids Res 32(Database Issue):D449-D451. (Pubitemid 38081696)
23. Peri S et al (2003) Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 13(10):2363-2371. (Pubitemid 37266003)
24. Hermjakob H et al (2004) IntAct: an open source molecular interaction database. Nucleic Acids Res 32(Database Issue):D452-D455. (Pubitemid 38081697)
25. Ceol A et al (2010) MINT, the molecular interaction database: 2009 update. Nucleic Acids Res 38(Database Issue):D532-D539.
26. Turner B et al (2010) iRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence. Database 2010:baq023.
27. Hernandez-Toro J, Prieto C, De Las Rivas J (2007) APID2NET: uni fi ed interactome graphic analyzer. Bioinformatics 23(18):2495-2497. (Pubitemid 47423852)
28. Perez-Fernandez J et al (2007) The 90S preribosome is a multimodular structure that is assembled through a hierarchical mechanism. Mol Cell Biol 27(15):5414-5429. (Pubitemid 47124395)
29. Yu H et al (2008) High-quality binary protein interaction map of the yeast interactome network. Science 322(5898):104-110.
30. Albert R (2005) Scale-free networks in cell biology. J Cell Sci 118(Pt 21):4947-4957. (Pubitemid 41672427)
31. Watts DJ, Strogatz SH (1998) Collective dynamics of 'small-world' networks. Nature 393(6684):440-442. (Pubitemid 28292183)
32. Albert R et al (2002) Statistical mechanics of complex networks. Rev Mod Phys 74(1):47.
33. Han JD et al (2004) Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430(6995): 88-93.
34. Jeong H et al (2001) Lethality and centrality in protein networks. Nature 411(6833):41-42. (Pubitemid 32428180)
35. Said MR et al (2004) Global network analysis of phenotypic effects: protein networks and toxicity modulation in Saccharomyces cerevisiae . Proc Natl Acad Sci USA 101(52): 18006-18011. (Pubitemid 40054065)
36. Shannon P et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498-2504. (Pubitemid 37428274)
37. Assenov Y et al (2008) Computing topological parameters of biological networks. Bioinformatics 24(2):282-284.
38. Bader GD, Hogue CW (2003) An automated method for fi nding molecular complexes in large protein interaction networks. BMC Bioinform 4:2.
39. Rivera CG, Vakil R, Bader JS (2010) NeMo: network module identi fi cation in Cytoscape. BMC Bioinform 11(Suppl 1):S61.
40. Satoh JI, Tabunoki H, Yamamura T (2009) Molecular network of the comprehensive multiple sclerosis brain-lesion proteome. Mult Scler 15(5):531-541
41. Goni J et al (2008) A computational analysis of protein-protein interaction networks in neurodegenerative diseases. BMC Syst Biol 2:52.
42. Soler-Lopez M et al (2010) Interactome mapping suggests new mechanistic details underlying Alzheimer's disease. Genome Res 21: 364-376.
43. Pujana MA et al (2007) Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 39(11):1338-1349. (Pubitemid 350035000)
44. Su J, Yoon BJ, Dougherty ER (2010) Identi fi cation of diagnostic subnetwork markers for cancer in human protein-protein interaction network. BMC Bioinform 11(Suppl 6):S8.
45. Wu ZJ et al (2010) Constructing the HBVhuman protein interaction network to understand the relationship between HBV and hepatocellular carcinoma. J Exp Clin Cancer Res 29:146.
46. Yao C et al (2010) Multi-level reproducibility of signature hubs in human interactome for breast cancer metastasis. BMC Syst Biol 4:151.
47. Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4(11):682-690.
48. Gandhi TK et al (2006) Analysis of the human protein interactome and comparison with yeast, worm and fl y interaction datasets. Nat Genet 38(3):285-293.
49. Jonsson PF, Bates PA (2006) Global topological features of cancer proteins in the human interactome. Bioinformatics 22(18):2291-2297. (Pubitemid 44390886)
50. Xu J, Li Y (2006) Discovering disease-genes by topological features in human protein-protein interaction network. Bioinformatics 22(22): 2800-2805. (Pubitemid 44742401)
51. Goh KI et al (2007) The human disease network. Proc Natl Acad Sci USA 104(21): 8685-8690.
52. Kitano H (2007) A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov 6(3):202-210. (Pubitemid 46344624)
53. Missiuro PV et al (2009) Information fl ow analysis of interactome networks. PLoS Comput Biol 5(4):e1000350.
54. Hwang WC, Zhang A, Ramanathan M (2008) Identi fi cation of information fl ow-modulating drug targets: a novel bridging paradigm for drug discovery. Clin Pharmacol Ther 84(5):563-572.
55. Grunberg R, Serrano L (2010) Strategies for protein synthetic biology. Nucleic Acids Res 38(8):2663-2675.
56. Florez AF et al (2010) Protein network prediction and topological analysis in Leishmania major as a tool for drug target selection. BMC Bioinform 11:484.
57. Liu X et al (2010) A network approach to predict pathogenic genes for Fusarium graminearum. PLoS One 5(10):e13021.
58. Wang Y et al (2010) Global protein-protein interaction network in the human pathogen Mycobacterium tuberculosis H37Rv. J Proteome Res 9(12):6665-6677.
59. Vicent S et al (2008) A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Cancer Res 68(7): 2275-2285. (Pubitemid 351521801)
60. Schrattenholz A, Groebe K, Soskic V (2010) Systems biology approaches and tools for analysis of interactomes and multi-target drugs. Methods Mol Biol 662:29-58.
61. Meyerson M, Gabriel S, Getz G (2010) Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11(10):685-696.
62. Schrattenholz A, Soskic V (2008) What does systems biology mean for drug development? Curr Med Chem 15(15):1520-1528. (Pubitemid 351997783)
63. Csermely P, Agoston V, Pongor S (2005) The ef fi ciency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 26(4):178-182. (Pubitemid 40432652)
64. Boran AD, Iyengar R (2010) Systems approaches to polypharmacology and drug discovery. Curr Opin Drug Discov Dev 13(3):297-309.
65. Fliri AF, Loging WT, Volkmann RA (2010) Cause-effect relationships in medicine: a protein network perspective. Trends Pharmacol Sci 31(11):547-555.
66. Chautard E, Thierry-Mieg N, Ricard-Blum S (2009) Interaction networks: from protein functions to drug discovery. A review. Pathol Biol (Paris) 57(4):324-333.
67. Barrett T et al (2011) NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic Acids Res 39(Database Issue): D1005-D1010.
68. Parkinson H et al (2011) ArrayExpress update-an archive of microarray and highthroughput sequencing-based functional genomics experiments. Nucleic Acids Res 39(Database Issue): D1002-D1004.
69. Carter GW (2005) Inferring network interactions within a cell. Brief Bioinform 6(4):380-389. (Pubitemid 43091943)
70. Deng M, Sun F, Chen T (2003) Assessment of the reliability of protein-protein interactions and protein function prediction. Pac Symp Biocomput 2003:140-151.
71. Lin CC et al (2010) Dynamic functional modules in co-expressed protein interaction networks of dilated cardiomyopathy. BMC Syst Biol 4:138
72. Bossi A, Lehner B (2009) Tissue speci fi city and the human protein interaction network. Mol Syst Biol 5:260.
73. Hu Z et al (2009) VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology. Nucleic Acids Res 37(Web Server Issue):W115-W121.
74. Cline MS et al (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2(10):2366-2382.
75. Gene Ontology Consortium (2010) The gene ontology in 2010: extensions and re fi nements. Nucleic Acids Res 38(Database Issue): D331-D335.
76. Ng A et al (2006) Resources for integrative systems biology: from data through databases to networks and dynamic system models. Brief Bioinform 7(4):318-330. (Pubitemid 44896735)
77. George RA et al (2006) Analysis of protein sequence and interaction data for candidate disease gene prediction. Nucleic Acids Res 34(19):e130.
78. Jiang JQ, Dress AW, Chen M (2010), Towards prediction and prioritization of disease genes by the modularity of human phenomegenome assembled network. J Integr Bioinform 7(2):149.
79. Lage K et al (2007) A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 25(3):309-316. (Pubitemid 46402863)
80. Wu X, Liu Q, Jiang R (2009) Align human interactome with phenome to identify causative genes and networks underlying disease families. Bioinformatics 25(1):98-104